Real-World Effectiveness of SGLT2 Inhibitors vs. GLP-1 Receptor Agonists in Patients With and Without Cardiovascular Disease

Citation
Patorno E, Pawar A, Schneeweiss S, et al. Diabetes 2019;68(Suppl 1):247-OR.